ROCO
4138
Market cap67mUSD
Oct 08, Last price
53.80TWD
1D
0.00%
1Q
5.70%
Jan 2017
21.69%
IPO
12.25%
Name
Dynamic Medical Technologies Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Dynamic Medical Technologies Inc., encompassing its various subsidiaries, operates within the aesthetic industry throughout Taiwan and Hong Kong. The company's primary focus involves the commercialization and upkeep of cosmetic laser and light-based equipment. Its extensive product range, which it both distributes and sells, includes specialized aesthetic medical instruments, body sculpting technologies, injectable dermal fillers, and high-grade cosmeceuticals, alongside a diverse selection of beauty treatment and cosmetic items. Additionally, Dynamic Medical Technologies delivers professional services such as training for aestheticians and consultation for clinical operational efficiency. The company is organized into distinct segments: Dynamic, Hong Kong Dynamic, Excelsior Beauty, and CYJ. Established in 1992, its main operational hub is situated in New Taipei City, Taiwan.
Key people
Chairman of the Board · since 2011
Kuan-Liang Chen
Chief Financial Officer · since 2025
Po-Yuan Chen
General Manager · since 2025
Chih-Hao Chiang
General Manager, Corporate Governance Officer · since 2025
Director · since 2020
Director · since 2019
Kuo-Lon Wu
Director · since 2025
Director · since 2020
Director · since 2024
Independent Director · since 2021
Fengzhi Lin
Independent Director · since 2024
Cuizhen Zeng
Independent Director · since 2024
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||